SCHEMBL12466932

SCHEMBL12466932

C[C@@H](O)[C@@H](C(=O)O)N(C=O)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.37
ALDH1A1 P00352 2/20 0.37
TP53 P04637 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPSR1 Q6W5P4 1/20 0.35
CYP2D6 P10635 1/20 0.35
MMP2 P08253 1/20 0.35
MMP9 P14780 1/20 0.35
MMP8 P22894 1/20 0.35
MMP13 P45452 1/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA4 P43681 1/20 0.35
ADAMTS4 O75173 1/20 0.35
MAPK1 P28482 1/20 0.34
KMT2A Q03164 2/20 0.34
GLA P06280 1/20 0.34
TSHR P16473 1/20 0.34
TRPM8 Q7Z2W7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7815263 0.80 ALDH1A1 (0.40) LMNAALDH1A1TP53SMN1; SMN2NPSR1
SCHEMBL10786707 0.80 ALDH1A1 (0.40) LMNAALDH1A1TP53SMN1; SMN2NPSR1
SCHEMBL6743611 0.80 ALDH1A1 (0.38) LMNAALDH1A1TP53SMN1; SMN2NPSR1
SCHEMBL10784586 0.76 NPSR1 (0.41) LMNAALDH1A1TP53SMN1; SMN2NPSR1
SCHEMBL149788 0.75 ALDH1A1 (0.40) LMNAALDH1A1TP53SMN1; SMN2NPSR1
SCHEMBL6743610 0.74 KMT2A (0.37) LMNAALDH1A1TP53SMN1; SMN2NPSR1
SCHEMBL28314846 0.73 NPSR1 (0.36) NPSR1
SCHEMBL11201182 0.73 FFAR2 (0.38) ALDH1A1MMP2MMP9MMP8MMP13
Phosphoric Acid SCHEMBL8412557 0.72 LMNA (0.38) LMNAALDH1A1TP53SMN1; SMN2NPSR1
SCHEMBL31016233 0.72 KMT2A (0.50) SMN1; SMN2NPSR1CHRNB2CHRNB4CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10597361-B2 Ethynylbenzene derivatives DUKE UNIVERSITY (US) 2020-03-24 US disclosed
US-20170349544-A1 Ethynylbenzene Derivatives DUKE UNIVERSITY 2017-12-07 US disclosed
US-9738604-B2 Ethynylbenzene derivatives DUKE UNIVERSITY (US) 2017-08-22 US disclosed
US-20130231323-A1 ETHYNYLBENZENE DERIVATIVES DUKE UNIVERSITY (US) 2013-09-05 US disclosed
WO-2012031298-A2 ETHYNYLBENZENE DERIVATIVES DUKE UNIVERSITY (US) 2012-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10597361-B2 Ethynylbenzene derivatives Q6ZSR9, EPX, ZYX LMNA 2493/4885ALDH1A1 1651/4885TP53 1439/4885
US-20170349544-A1 Ethynylbenzene Derivatives Q6ZSR9, EPX, ZYX LMNA 2493/4885ALDH1A1 1651/4885TP53 1439/4885
US-20130231323-A1 ETHYNYLBENZENE DERIVATIVES Q6ZSR9, EPX, ZYX LMNA 2493/4885ALDH1A1 1651/4885TP53 1439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.